Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine
Reference35 articles.
1. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101:1372–8.
2. Seeger H, Mueck AO, Lippert TH. Effects of valsartan and 17-beta-estradiol on the oxidation of low-density lipoprotein in vitro. Coron Artery Dis. 2000;11:347–9.
3. Raiden S, Giordano M, Andonegui G, et al. Losartan, s selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formyl-methionyl-leucyl-phenylalanine to neutrophil receptors. J Pharmacol Exp Ther. 1997;281:624–8.
4. Hornig B, Köhler C, Schlink D, et al. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B1-dependent mechanism. Hypertension. 2003;41:1092–6.
5. Volpe M, Paolis P. Angiotensin II AT” subtype receptors: an emerging target for cardiovascular therapy. Ital Heart J. 2000;1:96–103.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献